174 related articles for article (PubMed ID: 21441141)
1. Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.
Nakaya K; Tohyama J; Naik SU; Tanigawa H; MacPhee C; Billheimer JT; Rader DJ
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1276-82. PubMed ID: 21441141
[TBL] [Abstract][Full Text] [Related]
2. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages.
Iizuka M; Ayaori M; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Sasaki M; Komatsu T; Yogo M; Kishimoto Y; Kondo K; Ikewaki K
J Nutr Sci Vitaminol (Tokyo); 2012; 58(2):96-104. PubMed ID: 22790567
[TBL] [Abstract][Full Text] [Related]
3. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
[TBL] [Abstract][Full Text] [Related]
4. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
[TBL] [Abstract][Full Text] [Related]
5. Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist.
Mukherjee R; Locke KT; Miao B; Meyers D; Monshizadegan H; Zhang R; Search D; Grimm D; Flynn M; O'Malley KM; Zhang L; Li J; Shi Y; Kennedy LJ; Blanar M; Cheng PT; Tino J; Srivastava RA
J Pharmacol Exp Ther; 2008 Dec; 327(3):716-26. PubMed ID: 18799592
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
[TBL] [Abstract][Full Text] [Related]
7. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.
Jiang Z; Sang H; Fu X; Liang Y; Li L
Biotechnol Appl Biochem; 2015; 62(6):840-7. PubMed ID: 25496323
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Humanized IgG1 Antibody Promotes Reverse Cholesterol Transport through FcRn-ERK1/2-PPARα Pathway in Hepatocytes.
Li Z; Zhang Q; Liu X; Zhao M
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498935
[TBL] [Abstract][Full Text] [Related]
9. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
11. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
[TBL] [Abstract][Full Text] [Related]
12. Emodin enhances cholesterol efflux by activating peroxisome proliferator-activated receptor-γ in oxidized low density lipoprotein-loaded THP1 macrophages.
Fu X; Xu AG; Yao MY; Guo L; Zhao LS
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):679-84. PubMed ID: 24837536
[TBL] [Abstract][Full Text] [Related]
13. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
15. 13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages.
Kämmerer I; Ringseis R; Biemann R; Wen G; Eder K
Lipids Health Dis; 2011 Nov; 10():222. PubMed ID: 22129452
[TBL] [Abstract][Full Text] [Related]
16. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway.
Xu X; Li Q; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
Biochem Biophys Res Commun; 2013 Nov; 441(2):321-6. PubMed ID: 24140409
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.
Yin K; You Y; Swier V; Tang L; Radwan MM; Pandya AN; Agrawal DK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2432-42. PubMed ID: 26381871
[TBL] [Abstract][Full Text] [Related]
19. Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano.
Alexander ET; Weibel GL; Joshi MR; Vedhachalam C; de la Llera-Moya M; Rothblat GH; Phillips MC; Rader DJ
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1496-501. PubMed ID: 19661486
[TBL] [Abstract][Full Text] [Related]
20. The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalpha.
Johnston TP; Waxman DJ
J Pharm Pharmacol; 2008 Jun; 60(6):753-9. PubMed ID: 18498712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
